Solving the Problem of Insolubility: Part II
KinetiSol’s solvent-free mixing process turns “brick dust” drugs into stable amorphous dispersions
False
KinetiSol’s solvent-free mixing process turns “brick dust” drugs into stable amorphous dispersions
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
False
False
September 22, 2026
5 min read
CCRM CEO Michael May on quantum computing, commercialization, and the next era of cell therapy
September 21, 2026
5 min read
From isotope supply to reimbursement, the practical challenges shaping real-world delivery in oncology
September 15, 2026
4 min read
The Ascentage Pharma CEO on why next-generation small molecules are expanding into territory once reserved for biologics
September 14, 2026
5 min read
Scientists are already using AI in the lab – but many are doing so without the safeguards their employers may assume are in place
False
Affiliations:
Specialties:
Areas of Expertise: